Skip to content
Phoenix Joint Guide
Symptoms in one column, structure in the other

Phoenix Joint Guide

Straight answers about joint soreness and your choices

Morning stiffness can raise questions before breakfast. You may wonder whether soreness means more wear. You may also wonder if home care is enough or whether a procedure could help. The answers below tell you what each choice means and what to ask.

Write down the questions that match your joint. A short list can keep the visit focused.

What usually causes a sore joint?

Arthritis is common when stiffness follows rest and soreness grows with use. A tendon, muscle, or old injury can also hurt. Your doctor will check the tender area, swelling, strength, and movement. An X-ray may show wear or an older injury. One rough day can't tell you which cause is responsible.

What can I try at home first?

Ease back on the task that started the soreness, but keep gentle motion. A shorter walk may be better than full rest. A brace or cane can take strain off some joints. Ask whether an anti-inflammatory gel is safe for you. This is medicine rubbed on skin to calm swelling and soreness.

When does joint soreness need quick care?

Get prompt medical care when a joint is hot or badly swollen, especially with fever. After a fall, go promptly if you can't stand or the joint looks out of shape. A joint that stops moving also needs quick help. Sudden trouble with bladder or bowel control calls for urgent care. So do new numbness or lost strength.

What are PRP and concentrated PRP?

Doctors shorten platelet-rich plasma to PRP. Plasma is the liquid part of blood. Platelets are small pieces that help blood clot. A clinic spins blood drawn from you so the PRP contains more platelets. Concentrated PRP is meant to have a higher platelet amount than standard PRP. Because clinics prepare it differently, ask which kind is offered and why that kind fits your joint.

Does a worn X-ray mean I need surgery?

No. An X-ray shows wear, but it can't show how well you walk, sleep, or dress. Your exam also checks tender spots, strength, swelling, and movement. Surgery may need discussion when those daily tasks keep getting harder. Ask why surgery fits your exam now and what other choices remain.

What happens at a QC Kinetix consultation?

A medical provider means a clinician who can examine your joint. The clinician asks about soreness, checks movement, and reviews earlier care. QC Kinetix offers non-surgical regenerative treatments, meaning procedures made with blood or tissue. Take earlier X-rays, your written medicine names, and notes about a task you want to make easier.

Sources

  1. The RESTORE trial - a participant-, injector- and assessor-blinded RCT of 288 adults aged 50+ with symptomatic medial knee OA (Kellgren-Lawrence 2-3) - compared three weekly intra-articular PRP injections against saline placebo, with co-primary endpoints of 12-month knee pain and medial tibial cartilage volume on MRI. PRP did not beat placebo on either. It is the single best-designed test of the specific claim that PRP changes joint structure, and it was negative.

    Bennell KL, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.. JAMA, 2021. DOI: 10.1001/jama.2021.19415.

  2. A four-arm, multicentre, single-blind phase 2/3 randomized trial of 480 knee OA patients (KL II-IV) compared autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction and allogeneic umbilical-cord-tissue mesenchymal stromal cells against a corticosteroid injection control. At 12 months NONE of the three orthobiologic injections was superior to another, or to the corticosteroid control, and none of the four groups showed a significant change in MRI osteoarthritis score from baseline. No procedure-related serious adverse events occurred.

    Mautner K, et al. — Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial.. Nature medicine, 2023. DOI: 10.1038/s41591-023-02632-w.

  3. A 2026 systematic review and meta-analysis of 28 randomized trials of intra-articular mesenchymal stem cell-based therapies in knee OA found significant improvements in several pain and function measures (delta-VAS MD -1.67; KOOS pain MD 15.37) but NO significant difference in WOMAC, KOOS quality of life or the Lequesne index, and MRI-based WORMS scores were non-significant - indicating no consistent structural benefit. Its own conclusion: these therapies serve a primarily SYMPTOM-modifying rather than STRUCTURE-modifying role, with higher frequencies of local reactions to weigh against the symptomatic benefit.

    Awad G, et al. — Efficacy and safety of intra-articular mesenchymal stem cell-based therapies in knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials.. Clinical rheumatology, 2026. DOI: 10.1007/s10067-026-08042-w.

  4. FORWARD, the longest disease-modifying osteoarthritis drug trial reported to date, gave intra-articular sprifermin (a recombinant FGF-18) or placebo to knee OA patients and followed 378 of them for 5 years. Sprifermin produced a significant, sustained dose-response INCREASE in total femorotibial cartilage thickness versus placebo - and WOMAC pain improved about 50% from baseline in ALL groups, including placebo. It is the cleanest demonstration in the literature that adding measurable cartilage and relieving pain are two different results, and that one does not deliver the other.

    Eckstein F, et al. — Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study.. Annals of the rheumatic diseases, 2021. DOI: 10.1136/annrheumdis-2020-219181.

  5. A systematic review of the discordance between clinical and radiographic knee osteoarthritis: many people with severe-looking x-rays have little pain, and many with disabling pain have modest radiographic change. This is the reason a post-treatment scan is a poor proxy for how someone feels, in either direction.

    Bedson J, et al. — The discordance between clinical and radiographic knee osteoarthritis: a systematic search and summary of the literature.. BMC musculoskeletal disorders, 2008. DOI: 10.1186/1471-2474-9-116.

  6. FDA states plainly that no stem cell, exosome, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic-fluid product has been approved for the treatment of ANY orthopedic condition - it names osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain and shoulder pain individually. The only FDA-approved stem cell products in the United States are cord-blood-derived blood-forming stem cells for disorders of the hematopoietic system, and there are currently no FDA-approved exosome products.

    US Food and Drug Administration, Center for Biologics Evaluation and Research — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. FDA, 2020.

What to ask QC Kinetix about your soreness

QC Kinetix medical providers, meaning clinicians who examine joints, discuss non-surgical regenerative treatments made with your blood or tissue.

Book a free consultation